Tag archive for ‘Brent Saunders’
Kurt Tucholsky On Wednesday, May 13th, 2015

Actavis CEO: Teva-Mylan Deal to Create ‘Bad Blood’, Destroy Value

    As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of rival drug manufacturer Actavis, has raised concerns More...

Reuters On Wednesday, November 26th, 2014

Ackman’s Pershing Square sees big payoff from Allergan deal

–   Hedge fund mogul William Ackman told investors they could see a $6 billion payday when he closes the chapter on Allergan Inc., his firm’s biggest bet of 2014. One week after Allergan agreed More...

Tibi Singer On Wednesday, November 26th, 2014

Actavis Saves Allergan from Valeant Hostile Takeover with $66 Billion Deal, But Will Slash R&D

The seven-month battle over American Botox haven pharmaceutical company Allergan is over, after it accepted a friendly takeover bid from Irish integrated specialty pharmaceutical Actavis. The Actavis offer More...

Clive Minchom On Tuesday, February 18th, 2014

Actavis Agrees To Pay $25 Billion To Acquire Forest Laboratories – Carl Icahn Has 11% Position

– – International specialty pharmaceutical company Actavis, which is headquartered in Dublin,  Ireland, and listed on the New York Stock Exchange ACT (NYSE),  has entered into More...

Wordpress site Developed by Fixing WordPress Problems